Sally C. Pipes
Commentary
This November, Choose Wisely on Healthcare
And the two political parties have wildly different approaches to solving that problem. The Democrats believe that subjecting more of our healthcare system to government control is the answer. Republicans argue that competition, free markets, and private-sector ingenuity can bring about better care at lower cost. Read the full article ...
Sally C. Pipes
September 5, 2024
Commentary
Buffalo News
Stop directing healthcare funding to social issues
Several states are already using Medicaid funds for nonmedical services like housing and food assistance. It’s a dangerous overreach that threatens to undermine Medicaid’s core mission of providing health coverage for low-income and disabled Americans. Read the full article at Buffalo News
Sally C. Pipes
September 3, 2024
Commentary
Learn why drug price controls don't work
Don’t Buy Kamala Harris’ Anti-Price Gouging Plan
That may sound like standard progressive fare. But the means by which she’d try to achieve those goals is a scheme of price controls that could destroy entire sectors of the U.S. economy. Read the full article at Forbes
Sally C. Pipes
September 3, 2024
Commentary
Learn why support for single-payer continues to fall
Kamala Harris aims to hide her long record of backing Medicare for All
Just 37% of likely voters support a government takeover of the country’s health insurance system and a concomitant ban on private health insurance, according to a survey conducted by Echelon Insights and sponsored by the Pacific Research Institute. And support for such a single-payer system has been eroding, dropping three ...
Sally C. Pipes
September 2, 2024
Commentary
Read the latest on Biden administration's drug price controls
Drug Price Controls Underperform, Unworkable
According to the White House, the program will save the federal government an estimated $6 billion in 2026, the first year the new prices will be in effect, while reducing costs for seniors by $1.5 billion. Those figures might seem impressive. But they are almost certainly inflated. In fact, it’s ...
Sally C. Pipes
August 27, 2024
Commentary
Read the latest about the problems with PBMs
Insulin Lawsuits Obscure A Dirty Business
The plaintiffs say they’re fighting for patients. They’re less forthcoming about the fact that they’ve profited handsomely from the system they’re now decrying. For years, these cities and states have insisted on a cut—if not all—of the rebates that these pharmacy benefit managers extract from drug makers when negotiating over ...
Sally C. Pipes
August 26, 2024
Commentary
Read the latest about VP Harris' healthcare platform
Harris commits to worst of Biden healthcare policies
One proposal Harris has explicitly backed would enshrine President Joe Biden’s enhanced Obamacare subsidies, which are slated to expire in 2025. “Republicans want to let those credits expire, increasing premiums,” the Democratic platform asserts. “Democrats will fight to make them permanent.” Read the full article at the Washington Examiner
Sally C. Pipes
August 24, 2024
Commentary
Harris’ and Walz’s Healthcare Vision a Socialist One
Democrat presidential nominee Kamala Harris joined President Joe Biden at the White House last Thursday for an event on healthcare policy. The two presented a unified vision for the future of America’s health sector. But the space between them on this issue, historically speaking, is difficult to ignore. As recently as ...
Sally C. Pipes
August 21, 2024
Commentary
This Bipartisan Bill Would Upend America’s Pharmaceutical Industry
Vice President Kamala Harris and Minnesota Governor Tim Walz have pivoted hard to the center in recent weeks in their bid for the White House. But their records indicate that they’d launch even more government intervention in the healthcare market. Harris was the most progressive member of the Senate during ...
Sally C. Pipes
August 19, 2024
Commentary
How the GOP can get tough on health care
Nearly eight in 10 Americans worry “a great deal” or “a fair amount” about the availability and affordability of health care, according to polling from Gallup. So it’s surprising that the Republican Party’s platform this year doesn’t devote much space to the topic. It’s even largely silent on the Biden-Harris administration’s ...
Sally C. Pipes
August 18, 2024
This November, Choose Wisely on Healthcare
And the two political parties have wildly different approaches to solving that problem. The Democrats believe that subjecting more of our healthcare system to government control is the answer. Republicans argue that competition, free markets, and private-sector ingenuity can bring about better care at lower cost. Read the full article ...
Buffalo News
Stop directing healthcare funding to social issues
Several states are already using Medicaid funds for nonmedical services like housing and food assistance. It’s a dangerous overreach that threatens to undermine Medicaid’s core mission of providing health coverage for low-income and disabled Americans. Read the full article at Buffalo News
Learn why drug price controls don't work
Don’t Buy Kamala Harris’ Anti-Price Gouging Plan
That may sound like standard progressive fare. But the means by which she’d try to achieve those goals is a scheme of price controls that could destroy entire sectors of the U.S. economy. Read the full article at Forbes
Learn why support for single-payer continues to fall
Kamala Harris aims to hide her long record of backing Medicare for All
Just 37% of likely voters support a government takeover of the country’s health insurance system and a concomitant ban on private health insurance, according to a survey conducted by Echelon Insights and sponsored by the Pacific Research Institute. And support for such a single-payer system has been eroding, dropping three ...
Read the latest on Biden administration's drug price controls
Drug Price Controls Underperform, Unworkable
According to the White House, the program will save the federal government an estimated $6 billion in 2026, the first year the new prices will be in effect, while reducing costs for seniors by $1.5 billion. Those figures might seem impressive. But they are almost certainly inflated. In fact, it’s ...
Read the latest about the problems with PBMs
Insulin Lawsuits Obscure A Dirty Business
The plaintiffs say they’re fighting for patients. They’re less forthcoming about the fact that they’ve profited handsomely from the system they’re now decrying. For years, these cities and states have insisted on a cut—if not all—of the rebates that these pharmacy benefit managers extract from drug makers when negotiating over ...
Read the latest about VP Harris' healthcare platform
Harris commits to worst of Biden healthcare policies
One proposal Harris has explicitly backed would enshrine President Joe Biden’s enhanced Obamacare subsidies, which are slated to expire in 2025. “Republicans want to let those credits expire, increasing premiums,” the Democratic platform asserts. “Democrats will fight to make them permanent.” Read the full article at the Washington Examiner
Harris’ and Walz’s Healthcare Vision a Socialist One
Democrat presidential nominee Kamala Harris joined President Joe Biden at the White House last Thursday for an event on healthcare policy. The two presented a unified vision for the future of America’s health sector. But the space between them on this issue, historically speaking, is difficult to ignore. As recently as ...
This Bipartisan Bill Would Upend America’s Pharmaceutical Industry
Vice President Kamala Harris and Minnesota Governor Tim Walz have pivoted hard to the center in recent weeks in their bid for the White House. But their records indicate that they’d launch even more government intervention in the healthcare market. Harris was the most progressive member of the Senate during ...
How the GOP can get tough on health care
Nearly eight in 10 Americans worry “a great deal” or “a fair amount” about the availability and affordability of health care, according to polling from Gallup. So it’s surprising that the Republican Party’s platform this year doesn’t devote much space to the topic. It’s even largely silent on the Biden-Harris administration’s ...